Related Experiment Video
Updated: Apr 29, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
Syn-lethality: an integrative knowledge base of synthetic lethality towards discovery of selective anticancer
Xue-juan Li1, Shital K Mishra1, Min Wu2
1Bioinformatics Research Centre (BIRC), School of Computer Engineering, Nanyang Technological University, 50 Nanyang Avenue, Singapore 639798.
Abstract:
Synthetic lethality (SL) is a novel strategy for anticancer therapies, whereby mutations of two genes will kill a cell but mutation of a single gene will not. Therefore, a cancer-specific mutation combined with a drug-induced mutation, if they have SL interactions, will selectively kill cancer cells. While numerous SL interactions have been identified in yeast, only a few have been known in human. There is a pressing need to systematically discover and understand SL interactions specific to human cancer. In this paper, we present Syn-Lethality, the first integrative knowledge base of SL that is dedicated to human cancer. It integrates experimentally discovered and verified human SL gene pairs into a network, associated with annotations of gene function, pathway, and molecular mechanisms. It also includes yeast SL genes from high-throughput screenings which are mapped to orthologous human genes. Such an integrative knowledge base, organized as a relational database with user interface for searching and network visualization, will greatly expedite the discovery of novel anticancer drug targets based on synthetic lethality interactions. The database can be downloaded as a stand-alone Java application.
Insights
Synthetic lethality (SL) offers a new anticancer therapy approach. The Syn-Lethality knowledge base systematically identifies human cancer-specific SL gene pairs to discover novel drug targets.
Area of Science:
- Oncology
- Genetics
- Bioinformatics
Background:
- Synthetic lethality (SL) is a promising strategy for targeted cancer therapy.
- SL involves the combined mutation of two genes leading to cell death, while single mutations are tolerated.
- Few SL interactions are known in human cancers, necessitating systematic discovery.
Purpose of the Study:
- To present Syn-Lethality, the first integrative knowledge base for human cancer-specific SL interactions.
- To facilitate the discovery of novel anticancer drug targets through SL interactions.
- To provide a comprehensive resource for understanding SL in human cancer.
Main Methods:
- Integration of experimentally verified human SL gene pairs into a network.
- Inclusion of annotations for gene function, pathways, and molecular mechanisms.
- Mapping of yeast SL genes from high-throughput screenings to orthologous human genes.
- Development of a relational database with search and network visualization functionalities.
Main Results:
- Creation of Syn-Lethality, a dedicated knowledge base for human cancer SL.
- Integration of diverse data, including experimental findings and yeast orthologs.
- Development of a user-friendly interface for data exploration and network analysis.
Conclusions:
- The Syn-Lethality knowledge base significantly accelerates the identification of novel anticancer drug targets.
- This resource provides a foundation for deeper understanding and exploitation of SL in human cancer therapy.
- The database is available as a downloadable Java application for broader accessibility.
More Related Videos
07:23Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
15:04Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
Related Concept Videos
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes